LGVN Longeveron Inc.
Nasdaq · SEC CIK 1721484 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 196 since 2021-07-22, latest 2026-08-25 18:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Paletta George A. Jr. | Dir | — | — |
| Powell James Nathaniel | CEO | — | — |
| Blass Devin | CTO, SVP of CMC | — | — |
| Hajjar Roger Joseph | Dir | — | — |
| Jhaveri Nirav S. | CFO | — | — |
| Locklear Lisa | CFO | — | — |
| Agafonova Nataliya | Chief Medical Off | — | — |
| Desai Arjun JJ | Dir | — | — |
| Ungaro Ursula | Dir | — | — |
| Lehr Paul T | GC, Sec | — | — |
Transactions 180
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-12 | 2024-04-11 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO, Dir | P - Purchase | $2.35 | +10.6K | 19.6K | +118% | +$25.0K |
| DM | 2024-04-12 | 2024-04-10+ | LGVN | Soffer Rock | Dir | P - Purchase | $2.35 | +138.3K | 208.5K | +197% | +$325.0K |
| 2024-03-20 | 2024-03-12 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO, Dir | F - Tax | $0.54 | -32.9K | 89.8K | -27% | -$17.7K | |
| 2024-03-20 | 2024-03-12 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO, Dir | A - Grant | $0.00 | +80.2K | 122.6K | +189% | $0 | |
| 2024-01-25 | 2024-01-02 | LGVN | Agafonova Nataliya | Chief Medical Off | F - Tax | $1.32 | -3,074 | 20.8K | -13% | -$4,058 | |
| 2024-01-25 | 2024-01-02 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO, Dir | F - Tax | $1.32 | -5,123 | 42.4K | -11% | -$6,762 | |
| 2024-01-25 | 2024-01-02 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $1.32 | -992 | 142.4K | -0.7% | -$1,309 | |
| 2024-01-25 | 2024-01-02 | LGVN | Locklear Lisa | CFO | F - Tax | $1.32 | -4,098 | 36.8K | -10% | -$5,409 | |
| 2024-01-11 | 2024-01-10 | LGVN | Ross Cathy | Dir | P - Purchase | $1.31 | +5,000 | 10.0K | +100% | +$6,550 | |
| M | 2024-01-02 | 2023-12-28+ | LGVN | Baluch Khoso | Dir | P - Purchase | $1.42 | +10.0K | 6,678 | New | +$14.2K |
| 2023-12-29 | 2023-12-28 | LGVN | PFEFFER JEFFREY | Dir | P - Purchase | $1.35 | +10.0K | 15.0K | +200% | +$13.5K | |
| 2023-10-04 | 2023-10-02 | LGVN | Locklear Lisa | CFO | F - Tax | $2.29 | -4,078 | 40.9K | -9% | -$9,339 | |
| 2023-10-04 | 2023-10-02 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $2.29 | -815 | 143.4K | -0.6% | -$1,866 | |
| 2023-10-04 | 2023-10-02 | LGVN | Agafonova Nataliya | Chief Medical Off | F - Tax | $2.29 | -3,059 | 23.9K | -11% | -$7,005 | |
| D | 2023-09-22 | 2023-09-21 | LGVN | Hare Joshua | CSO, Dir, 10% | M - OptEx | $3.00 | +5,000 | 7.83M | +0.1% | +$15.0K |
| D | 2023-09-21 | 2023-09-20 | LGVN | Lehr Paul T | GC, Sec | M - OptEx | $3.00 | +2,000 | 144.2K | +1% | +$6,000 |
| D | 2023-09-14 | 2023-09-12 | LGVN | Hare Joshua | CSO, Dir, 10% | M - OptEx | $3.00 | +30.0K | 7.82M | +0.4% | +$90.0K |
| D | 2023-09-13 | 2023-09-12 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO | M - OptEx | $3.00 | +10.0K | 47.6K | +27% | +$30.0K |
| D | 2023-09-13 | 2023-09-12 | LGVN | Locklear Lisa | CFO | O - OTM Ex | $3.00 | +5,000 | 45.0K | +12% | +$15.0K |
| D | 2023-09-12 | 2023-09-08 | LGVN | Soffer Rock | Dir | M - OptEx | $3.00 | +30.0K | 702.4K | +4% | +$90.0K |
| 2023-09-06 | 2023-09-01 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO | F - Tax | $2.64 | -4,323 | 37.6K | -10% | -$11.4K | |
| 2023-08-22 | 2023-08-18 | LGVN | Agafonova Nataliya | Chief Medical Off | F - Tax | $3.36 | -3,081 | 26.9K | -10% | -$10.4K | |
| 2023-08-22 | 2023-08-18 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $3.25 | -767 | 142.2K | -0.5% | -$2,493 | |
| 2023-08-22 | 2023-08-18 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO | F - Tax | $3.25 | -4,292 | 41.9K | -9% | -$13.9K | |
| 2023-08-02 | 2023-07-31 | LGVN | Locklear Lisa | CFO | A - Grant | $0.00 | +40.0K | 40.0K | New | $0 | |
| 2023-08-02 | 2023-07-24 | LGVN | Agafonova Nataliya | Chief Medical Off | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 | |
| 2023-07-17 | 2023-04-05 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO | F - Tax | $2.61 | -3,819 | 46.2K | -8% | -$9,968 | |
| M | 2023-06-29 | 2023-06-27+ | LGVN | Clavijo James | CFO, Treas | S - Sale | $3.47 | -23.5K | 52.3K | -31% | -$81.5K |
| 2023-06-12 | 2023-06-02 | LGVN | Clavijo James | CFO, Treas | F - Tax | $3.42 | -752 | 70.8K | -1% | -$2,572 | |
| 2023-06-12 | 2023-06-09 | LGVN | Baluch Khoso | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 | |
| 2023-06-12 | 2023-06-09 | LGVN | PFEFFER JEFFREY | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 | |
| 2023-06-09 | 2023-06-02 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $3.25 | -3,247 | 143.0K | -2% | -$10.6K | |
| 2023-06-09 | 2023-06-02 | LGVN | Clavijo James | CFO, Treas | F - Tax | $3.25 | -3,247 | 71.6K | -4% | -$10.6K | |
| 2023-04-05 | 2023-04-03 | LGVN | Clavijo James | CFO, Treas | F - Tax | $2.61 | -815 | 74.8K | -1% | -$2,127 | |
| 2023-04-05 | 2023-04-03 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $2.61 | -815 | 146.2K | -0.6% | -$2,127 | |
| 2023-03-02 | 2023-03-01 | LGVN | Hashad Mohamed Wa'el Ahmed | CEO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 | |
| 2023-01-30 | 2023-01-27 | LGVN | Hare Joshua | CSO, Dir, 10% | S - Sale | $4.28 | -20.0K | 7.79M | -0.3% | -$85.6K | |
| 2023-01-04 | 2023-01-03 | LGVN | Clavijo James | CFO, Treas | F - Tax | $3.37 | -1,288 | 75.6K | -2% | -$4,341 | |
| 2023-01-04 | 2023-01-03 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $3.37 | -1,472 | 147.0K | -1.0% | -$4,961 | |
| 2022-12-05 | 2022-12-02 | LGVN | Hare Joshua | CSO, Dir, 10% | S - Sale | $3.74 | -20.0K | 7.81M | -0.3% | -$74.8K | |
| 2022-11-18 | 2022-11-16 | LGVN | Hare Joshua | CSO, Dir, 10% | A - Grant | $0.00 | +48.1K | 7.86M | +0.6% | $0 | |
| 2022-10-18 | 2022-10-12 | LGVN | Hare Joshua | CSO, Dir, 10% | S - Sale | $3.61 | -100.0K | 7.81M | -1% | -$361.0K | |
| 2022-10-05 | 2022-10-03 | LGVN | Clavijo James | CFO, Treas | F - Tax | $3.75 | -1,256 | 76.9K | -2% | -$4,710 | |
| 2022-10-05 | 2022-10-03 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $3.75 | -1,435 | 148.5K | -1.0% | -$5,381 | |
| 2022-07-05 | 2022-07-01 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $5.94 | -1,629 | 149.9K | -1% | -$9,676 | |
| 2022-07-05 | 2022-07-01 | LGVN | Clavijo James | CFO, Treas | F - Tax | $5.94 | -1,426 | 78.2K | -2% | -$8,470 | |
| D | 2022-06-07 | 2022-06-03 | LGVN | Lehr Paul T | GC, Sec | A - Grant | $0.00 | +40.0K | 151.6K | +36% | $0 |
| 2022-06-07 | 2022-06-03 | LGVN | Clavijo James | CFO, Treas | A - Grant | $0.00 | +40.0K | 116.6K | +52% | $0 | |
| 2022-06-07 | 2022-06-03 | LGVN | Clavijo James | CFO, Treas | S - Sale | $8.26 | -37.0K | 79.6K | -32% | -$305.2K | |
| M | 2022-05-24 | 2022-05-20+ | LGVN | Soffer Rock | Dir | S - Sale | $7.83 | -19.5K | 676.4K | -3% | -$152.7K |
| 2022-05-19 | 2022-05-17 | LGVN | Soffer Rock | Dir | J - Other | $0.00 | +500.2K | 691.9K | +261% | $0 | |
| I | 2022-05-19 | 2022-05-17 | LGVN | Soffer Donald M | Dir | J - Other | $0.00 | -7.02M | 0 | -100% | $0 |
| 2022-05-19 | 2022-05-17 | LGVN | Soffer Donald M | Dir | J - Other | $0.00 | +6.54M | 6.69M | +4,123% | $0 | |
| 2022-05-19 | 2022-05-17 | LGVN | DS MED LLC | 10% | J - Other | $0.00 | -7.02M | 0 | -100% | $0 | |
| M | 2022-04-20 | 2022-04-18+ | LGVN | Hare Joshua | CSO, Dir, 10% | S - Sale | $10.00 | -20.0K | 7.91M | -0.3% | -$200.0K |
| I | 2022-04-18 | 2022-04-13 | LGVN | Soffer Donald M | Dir | J - Other | $0.00 | -748.7K | 7.02M | -10% | $0 |
| 2022-04-15 | 2022-04-13 | LGVN | DS MED LLC | 10% | J - Other | $0.00 | -748.7K | 7.02M | -10% | $0 | |
| 2022-04-15 | 2022-04-13 | LGVN | Soffer Rock | Dir | J - Other | $0.00 | +139.9K | 191.7K | +270% | $0 | |
| DMA | 2022-04-12 | 2022-04-04 | LGVN | Min Kwan-Hong Christopher | Chief Medical Off | A - Grant | $0.00 | +152.3K | 152.0K | New | $0 |
| DA | 2022-04-12 | 2022-04-04 | LGVN | Min Kwan-Hong Christopher | Chief Medical Off | F - Tax | $0.00 | -357 | 1,978 | -15% | $0 |
| 2022-04-08 | 2022-04-04 | LGVN | Green Geoff | CEO | F - Tax | $15.61 | -1,840 | 133.9K | -1% | -$28.7K | |
| 2022-04-08 | 2022-04-04 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $15.61 | -1,472 | 111.6K | -1% | -$23.0K | |
| 2022-04-08 | 2022-04-04 | LGVN | Clavijo James | CFO, Treas | F - Tax | $15.61 | -1,288 | 76.6K | -2% | -$20.1K | |
| DM | 2022-04-06 | 2022-04-04 | LGVN | Min Kwan-Hong Christopher | Chief Medical Off | A - Grant | $0.00 | +152.3K | 2,335 | New | $0 |
| 2022-02-25 | 2022-02-25 | LGVN | Girolamo Todd C | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 | |
| 2022-01-05 | 2022-01-03 | LGVN | Clavijo James | CFO, Treas | F - Tax | $12.09 | -1,736 | 77.9K | -2% | -$21.0K | |
| 2022-01-05 | 2022-01-05 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $12.09 | -3,316 | 113.0K | -3% | -$40.1K | |
| 2022-01-05 | 2022-01-03 | LGVN | Green Geoff | CEO | F - Tax | $12.09 | -3,979 | 135.7K | -3% | -$48.1K | |
| 2021-10-14 | 2021-10-13 | LGVN | Green Geoff | CEO | P - Purchase | $3.81 | +1,000 | 139.7K | +0.7% | +$3,810 | |
| 2021-10-14 | 2021-10-12 | LGVN | Hare Joshua | CSO, Dir, 10% | P - Purchase | $3.69 | +2,500 | 7.93M | +0.0% | +$9,225 | |
| M | 2021-10-13 | 2021-10-11+ | LGVN | Soffer Rock | Dir | P - Purchase | $3.66 | +19.9K | 51.8K | +62% | +$72.9K |
| M | 2021-10-12 | 2021-10-07+ | LGVN | Hare Joshua | CSO, Dir, 10% | P - Purchase | $3.39 | +5,000 | 7.93M | +0.1% | +$16.9K |
| 2021-10-12 | 2021-10-07 | LGVN | Clavijo James | CFO, Treas | P - Purchase | $3.34 | +5,000 | 79.6K | +7% | +$16.7K | |
| 2021-10-12 | 2021-10-07 | LGVN | Lehr Paul T | GC, Sec | P - Purchase | $3.34 | +1,750 | 116.4K | +2% | +$5,845 | |
| 2021-10-01 | 2021-10-01 | LGVN | Clavijo James | CFO, Treas | F - Tax | $3.65 | -19.1K | 74.6K | -20% | -$69.5K | |
| 2021-10-01 | 2021-10-01 | LGVN | Green Geoff | CEO | F - Tax | $3.65 | -43.9K | 138.7K | -24% | -$160.3K | |
| 2021-10-01 | 2021-10-01 | LGVN | Lehr Paul T | GC, Sec | F - Tax | $3.65 | -38.8K | 114.6K | -25% | -$141.4K | |
| D | 2021-07-22 | 2021-07-20 | LGVN | Lehr Paul T | GC, Sec | A - Grant | $0.00 | +6,167 | 153.4K | +4% | $0 |
| D | 2021-07-22 | 2021-07-20 | LGVN | Green Geoff | CEO | A - Grant | $0.00 | +8,223 | 182.7K | +5% | $0 |
| D | 2021-07-22 | 2021-07-20 | LGVN | Hare Joshua | CSO, Dir, 10% | A - Grant | $0.00 | +12.3K | 7.93M | +0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations